We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+6.86%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$251M
AUM Growth
-$3.22M
Cap. Flow
-$11.3M
Cap. Flow %
-4.49%
Top 10 Hldgs %
65.99%
Holding
155
New
6
Increased
7
Reduced
10
Closed
7
Avg Time Held
1.1 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$3.01M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$2.28M
3
ALKS icon
Alkermes
ALKS
+$2.03M
4
CHRS icon
Coherus Oncology
CHRS
+$1.45M
5
MCRB icon
Seres Therapeutics
MCRB
+$843K

Top Sells

Rank Stock Value
1
FBRT icon
Franklin BSP Realty Trust
FBRT
+$5.67M
2
GCVRZ
Sanofi Contingent Value Rights
GCVRZ
+$3.05M
3
VKTX icon
Viking Therapeutics
VKTX
+$2.61M
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$2.38M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$1.51M

Sector Composition

Rank Sector Weight
1 Healthcare 30.52%
2 Materials 30.19%
3 Financials 13.16%
4 Industrials 6.99%
5 Miscellaneous 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CLMT icon
1
Calumet Specialty Products
CLMT
$5.06B
$72.6M 28.88%
4,576,000
– –
2021 Q4
6 quarters
APO icon
2
Apollo Global Management
APO
$67B
$17.3M 6.88%
225,000
– –
2021 Q4
6 quarters
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.2T
$13.6M 5.4%
112,220
– –
2021 Q4
6 quarters
FTAI icon
4
FTAI Aviation
FTAI
$16.8B
$13.5M 5.36%
425,000
– –
2021 Q4
6 quarters
DCGO icon
5
DocGo
DCGO
$26.9M
$13.1M 5.22%
1,400,000
– –
2021 Q4
6 quarters
MDWT
6
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$10.3M 4.09%
390,241
– –
2021 Q4
6 quarters
LGND icon
7
Ligand Pharmaceuticals
LGND
$5.88B
$8.29M 3.3%
115,000
– –
2021 Q4
6 quarters
FBRT icon
8
Franklin BSP Realty Trust
FBRT
$500M
$6.08M 2.42%
429,047
-430,000
-50% -$5.67M
2021 Q4
6 quarters
MITAW icon
9
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$5.69M 2.27%
495,000
– –
2021 Q4
6 quarters
OABI icon
10
OmniAb
OABI
$662M
$5.46M 2.18%
1,086,505
– –
2022 Q4
2 quarters
AGAC.WS
11
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$5.18M 2.06%
450,750
– –
2021 Q4
6 quarters
ARDX icon
12
Ardelyx
ARDX
$824M
$5.08M 2.02%
1,500,000
– –
2022 Q3
3 quarters
AVDL
13
DELISTED
Avadel Pharmaceuticals
AVDL
$3.97M 1.58%
240,629
-50,484
-17% -$656K
2021 Q4
6 quarters
PFE icon
14
Pfizer
PFE
$166B
$3.58M 1.42%
97,537
– –
2021 Q4
6 quarters
ISEE
15
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$3.42M 1.36%
87,000
+22,000
+34% +$777K
2023 Q1
1 quarter
MDGL icon
16
Madrigal Pharmaceuticals
MDGL
$10.6B
$3.23M 1.29%
14,000
– –
2022 Q3
3 quarters
SGEN
17
DELISTED
Seagen Inc. Common Stock
SGEN
$3.18M 1.26%
16,500
+11,500
+230% +$2.28M
2023 Q1
1 quarter
JPM icon
18
JPMorgan Chase
JPM
$890B
$3.05M 1.21%
20,985
– –
2021 Q4
6 quarters
SNY icon
19
Sanofi
SNY
$95.3B
$3.02M 1.2%
+56,000
New +$3.01M
2023 Q2
0 quarters
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.8M 1.11%
27,190
-14,300
-34% -$1.51M
2021 Q4
6 quarters
JAZZ icon
21
Jazz Pharmaceuticals
JAZZ
$13.6B
$2.78M 1.11%
22,411
– –
2021 Q4
6 quarters
CSX icon
22
CSX Corp
CSX
$89.4B
$2.39M 0.95%
70,000
– –
2022 Q4
2 quarters
GSK icon
23
GSK
GSK
$95.9B
$2.32M 0.92%
65,000
– –
2022 Q3
3 quarters
MCRB icon
24
Seres Therapeutics
MCRB
$24.3M
$2.25M 0.9%
23,500
+7,750
+49% +$843K
2022 Q3
3 quarters
ALKS icon
25
Alkermes
ALKS
$6.56B
$2.1M 0.83%
+67,000
New +$2.03M
2023 Q2
0 quarters
1
2 3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q2 2023 Portfolio in Review

As of Q2 2023, David M. Knott Jr held 155 positions worth $251M, down 1.3% from $254M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

David M. Knott Jr withdrew a net $11.3M in Q2 2023, closing 7 positions and reducing 10 holdings. Its most notable exit was Sanofi Contingent Value Rights, an estimated $3.05M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Materials and Financials.

Against the trend, David M. Knott Jr opened a new position in Sanofi worth $3.02M.

  • David M. Knott Jr's largest Q2 2023 buy was Sanofi: 56,000 shares worth $3.02M.
  • David M. Knott Jr added most to Seagen Inc. Common Stock in Q2 2023, an estimated $2.28M increase.
  • David M. Knott Jr's biggest Q2 2023 reduction was Franklin BSP Realty Trust, cutting an estimated $5.67M.
  • David M. Knott Jr fully exited Sanofi Contingent Value Rights in Q2 2023, selling an estimated $3.05M.
  • David M. Knott Jr's ten largest holdings make up 66% of its $251M portfolio in Q2 2023.
  • David M. Knott Jr opened 6 new positions and closed 7 in Q2 2023.
  • David M. Knott Jr's portfolio value fell 1.3% quarter-over-quarter to $251M.

Based on David M. Knott Jr's 13F filing for Q2 2023, filed 11 Aug 2023.